Cite
APA Citation
Chodorge, M., Celeste, A., Grimsby, J., Konkar, A., Davidsson, P., Fairman, D., Jenkinson, L., Naylor, J., White, N., Seaman, J., Dickson, K., Kemp, B., Spooner, J., Rossy, E., Hornigold, D., Trevaskis, J., Bond, N., London, T., Buchanan, A., Vaughan, T., Rondinone, C., & Osbourn, J. (2018). engineering of a GLP-1 analogue peptide/anti-PCSK9 antibody fusion for type 2 diabetes treatment. Scientific reports, 8(1), 1–14. http://access.bl.uk/ark:/81055/vdc_100099698518.0x000030